PALISADE BIO, INC. (PALI) Profit Margins
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
PALIPALISADE BIO, INC.Follow PALI — free
—
Price chart with a free account
- Market cap
- 231.8M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 9 Nov, in 16 days
| Line | FY2011 Dec 11 | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating margin | -3325.6% | -2491.1% | -11385.4% | -92581.4% | -183896.8% | -127027.2% | -5118.1% | -3176.7% | -56071.8% | -68764.8% | — | — | -5228.0% | — | — | — | |
| Net margin | -3204.7% | -2482.5% | -18029.0% | -120154.7% | -200671.0% | -129721.8% | -6025.4% | -1894.1% | -54252.6% | -76346.2% | — | — | -4920.0% | — | — | — | |
| FCF margin | -2123.0% | -2089.0% | -9742.7% | -63264.4% | -183430.3% | -96726.6% | -5164.4% | -2959.3% | — | -35310.7% | — | — | -4454.8% | — | — | — |
USD millions · SEC XBRL
Every figure on this page comes from PALISADE BIO, INC.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.